ADVANCED ENDOMETRIAL CANCER
Clinical trials for ADVANCED ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced endometrial cancer: major trial tests promising drug combo
Disease control Not yet recruitingThis study aims to see if adding a new drug called EG-007 to the standard two-drug treatment (lenvatinib plus pembrolizumab) works better for women with advanced or recurrent endometrial cancer. It will enroll about 450 patients whose cancer has progressed after initial chemother…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE3 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo tested for Tough-to-Treat uterine cancer
Disease control Not yet recruitingThis study aims to check if adding a repurposed drug called EG-007 to the standard two-drug combination (lenvatinib and pembrolizumab) is safe for women with advanced endometrial cancer that has returned after chemotherapy. It will enroll about 28 women whose cancer is not a spec…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC